Adsorption of fibrinogen and some other proteins from blood plasma at a variety of solid surfaces

Publisher Website
Google Scholar
Abstract
—Enzyme linked immunosorbent assay (ELISA) was used for the estimation of protein adsorption from blood plasma at some model solid surfaces. The majority of those surfaces were made in the wells of microtiterplates of polystyrene commonly used for ELISA purposes. Three of the model surfaces were made by radio frequency plasma discharge polymerization (RFPD) of the microtiterplates of polystyrene. The monomers we used were diaminocyclohexane, hexamethylenedisiloxane, and acrylic acid. Other surfaces investigated were: unmodified polystyrene, oxidized polystyrene, hydrophilic silicon oxide, and methylized silicon oxide. Two substances, Tween and bovine serum albumin (BSA), for the prevention of unintended adsorption of ELISA conjugate were also tested and the BSA method was found to be superior for this kind of investigation. Human blood plasma at different dilutions was incubated in the surface-modified microtiterplates followed by incubation of rabbit antibodies against fibrinogen (FG), fibronectin (FN), human serum albumin (HSA), complement factor 3 (C3), and immunoglobulin G (IgG). Visualization of bound antibodies was then made by standard ELISA procedure. At low blood plasma concentrations (plasma dil 1/1000), anti-IgG and anti-HSA were detected at high levels at the majority of surfaces. At high blood plasma concentration (plasma dil 1/10), anti-FG dominated at most surfaces. ELISA activity of FN and C3 were low at most of the surfaces at both plasma concentrations. An 'optimum' plasma dilution for the detection of surface bound FG (the Vroman effect) was not found with the use of the ELISA on any of the surfaces except for the silicon oxide surface. This is in contrast to findings by others who had used isotope-labelled fibronogen diluted in plasma. However, 'false' Vroman effects occured if nonionic surfactant was used for the prevention of unspecific binding in the ELISA.